Biological concepts – ploidy, polyploidy, aneuploidy,
cancer, therapy-induced senescence
We can argue about whether your genes or your upbringing is more important for making you who you are (nature vs. nurture), but no one is going to argue that your chromosomes aren’t important in the process.
Mom and Dad both contributed to your chromosome number, you
got a copy of each chromosome from each parent, so you ended up with 2 copies of
each, a state of being diploid (di = two, ploos = fold, and –oid =
like). So what if you weren’t diploid, is it a good thing or a bad thing? You
know there must be exceptions.
Let’s start with how offspring get their DNA. In sexual reproduction, the rule is that
the female and male each contributes half the genetic material to the offspring.
Humans, for example, have 23 different pairs chromosomes, one from each pair
comes from the egg and one from the sperm.
The egg and sperm then each have just half of the full
complement of chromosomes. Therefore, the egg and
sperm are termed haploid (hap =
single). Ploidy in general refers to
the number of copies of whole sets of chromosomes in the nucleus. The haploid
sperm meets the haploid egg, they date for a while, and then voila, a diploid
zygote that turns into a teenager one day.
Fully 10% of spontaneous abortions in humans are due to the
presence of polyploid fetuses, usually triploid or tetraploid. There are
regulatory patterns in effect in mammals that just can’t deal with additional
copies of chromosomes and the genes they hold.
For every gene whose product performs a function, our cells
make a certain amount of that protein, not too much or to little - just enough
to do its job. What if we then add
two more copies of that gene by being tetraploid? This is called dosage imbalance, and it may cause double
the amount of that protein to be made, or even more. This could severely affect
that biochemical pathway.
If there is not a regulatory mechanism to account for the
additional protein, the polyploid problem can be big enough to cause
spontaneous abortion. Now imagine that the genes that produce regulatory
proteins to control whole biochemical pathways are there in higher numbers – it
isn’t hard to understand that this could wreak havoc with fetal development.
Females usually have two copies of the X chromosome,
but only one functions in any given cell. This X inactivation is one type of dosage
compensation and we will talk about it later in this series of posts. With
additional X chromosomes, X inactivation controls may not be strong enough to
limit the effect of X-linked genes. The problem could also occur in males with
extra Y chromosomes, since there isn’t a Y inactivation pathway. Sex
chromosomes account for sexual development of the fetus; polyploidy can
lead to problems in development that are incompatible with survival.
Current hypotheses state that aneuploidy in most cancers
starts out as tetraploidy; a 4n condition resulting from inappropriate
replication without mitosis (called endomitosis,
more on this next week), or from the merging of two cancer cell nuclei to form
one 4n cell.
The formation of tetraploid cancer cells has many
ramifications, including messing up the cell's system for dividing
up the chromosomes between the daughter cells during mitosis. If they don’t get
divided equally, you could end up with some having too many copies of individual
chromosomes, and some with too few copies – aneuploidy. So what induces
tetraploidy in the cancer cells? We don’t really know, but is the source of a current
argument in the cancer field.
Sounds good doesn’t it? Some groups are looking to use
TCS in cancer therapy, but other groups are warning that TCS may be a harbinger
of bad things to come. Some cancer cells can escape TCS and become very nasty.
A group in Seattle has done significant work in this area, first showing that it is a cell cycle regulating protein called cdc2/cdk1 that
allows the cells to enter senescence. Their 2011 paper showed that this also promotes expression
of proteins that stop the cell from undergoing apoptosis (killing itself). If the cells escape from
TCS, they are now primed to resist all treatment efforts to make them undergo
apoptosis. They may be super-cancer cells.
This same group published in 2012 that TCS also promotes polyploidy development
in the cancer cells. Their data indicates that polyploid development increases the chance that the cancer cells
will escape senescence and begin to proliferate again. Their longitudinal study
also indicated that TCS induction led to poorer outcomes for a group of
patients with a certain type of lung cancer. Maybe telling cancer cells to go
to sleep isn’t such a good idea, they don’t wake up nicely.
So polyploidy in mammals is a big no-no! Cancer and abortion aren't harbingers a of a long-life. But there is an exception - I give you the red vizcacha rat (Tympnoctomys barrerae). A cute little
rodent, T. barrerae lives exclusively
in the desert region of west-central Argentina. He seems to survive just fine
being tetraploid, having an amazing 4x = 2n = 102 chromosomes! He even has a cousin that is reputedly tetraploid as well.
The reigning hypothesis is that T. barrerae developed as a polyploid species because of a meiotic error in his close relative, the mountain vizcacha rat (Octomys mimax), who has a diploid number of chromosome set at 56. But we had better study he and his cousin quickly, as their habitats are being destroyed at an alarming rate. In only a few years, there may be no red or mountain vizcacha rats left in the wild. Wouldn’t be awful if we lost this exception and then found out that it could have helped us conquer cancer?
The math doesn’t suggest that T. barrerae resulted from a simple meiotic error in its cousin
(56+56≠102),
so a study was undertaken to investigate whether the large genome size of the
red vizcacha rat could have developed purely from duplication of repeated
sequences. Using techniques like self-genomic in situ hybridization and whole
genome comparative genomic hybridization, T.
barrerae (tetraploid) and O. mimax (diploid) were
compared for similar sequences and repeats of the same sequences.
The results, published in 2012 in the journal Genome, indicate that despite some repetitive sequences
around the centromeres of the chromosomes, it does not appear that the large
genome is the result of sequence duplications. Comparative anaylsis with O. mimax also shows differences that do
not suggest a mere doubling of the genome. Therefore, best evidence now says
that T. barrerae evolved as a result
of some hybridization of the mountain vizcacha rat and another species, with or
without subsequent loss of some chromosomes pairs.
But even more stunning, experiments to look at the amount of
protein made from certain crucial genes in T.
barrerae show that it has the same amount of gene function as its diploid
cousins. The rat has found some way to silence the extra copies of many of its genes.
Scientists better keep looking at this exceptional animal.
Good thing we don’t have to worry about tetraploidy; it just makes life difficult. Thankfully, we don’t have any cells that are polyploid --- do we? We
specialize in exceptions here, so you bet we do. And what’s more, we can’t live
without them.
Suárez-Villota, E., Vargas, R., Marchant, C., Torres, J., Köhler, N., Núñez, J., de la Fuente, R., Page, J., Gallardo, M., & Jenkins, G. (2012). Distribution of repetitive DNAs and the hybrid origin of the red vizcacha rat (Octodontidae) Genome, 55 (2), 105-117 DOI: 10.1139/G11-084
Wang, Q., Wu, P., Dong, D., Ivanova, I., Chu, E., Zeliadt, S., Vesselle, H., & Wu, D. (2012). Polyploidy road to therapy-induced cellular senescence and escape International Journal of Cancer DOI: 10.1002/ijc.27810
Wang, Q., Wu, P., Dong, D., Ivanova, I., Chu, E., Zeliadt, S., Vesselle, H., & Wu, D. (2012). Polyploidy road to therapy-induced cellular senescence and escape International Journal of Cancer DOI: 10.1002/ijc.27810
For
more information or classroom activities, see:
Diploid/haploid
-
Polyploidy
–
Therapy
induced cell senescence –
No comments:
Post a Comment